Nancy J. Tarbell, MD, is Dean for Academic and Clinical Affairs and the C.C. Wang Professor of Radiation Oncology at Harvard Medical School. Previously, she led pediatric radiation oncology at Massachusetts General Hospital and Children’s Hospital Boston. At Massachusetts General Hospital, Dr. Tarbell was the founding director of the Office for Women’s Careers and the Center for Faculty Development.

Dr. Tarbell is an internationally recognized expert in pediatric oncology and, in particular, pediatric brain tumors. Consistently listed in The Best Doctors of America (Woodward and White), Dr. Tarbell serves on the national Children’s Oncology Group Brain Tumor Committee. She was elected to the Institute of Medicine of the National Academies in 2002 and has authored more than 300 original publications and book chapters. Dr. Tarbell is co-editor of Pediatric Radiation Oncology, now in its 5th edition.

Dr. Tarbell is a longstanding advocate for faculty development initiatives including mentoring programs for junior faculty and numerous efforts on behalf of women and minorities. She recently led the HMS-wide Task Force on Faculty Development and Diversity, which has defined and prioritized faculty development and diversity enhancements within the HMS community, providing a foundation for the creation of new opportunities for HMS faculty and trainees.

As Dean for Academic and Clinical Affairs, Dr. Tarbell oversees the Office for Faculty Affairs, the Office for Faculty and Research Integrity, the Office for Diversity and Community Partnership, and several HMS-wide centers and divisions. In addition, her office is responsible for conducting clinical department reviews and has oversight of affiliation agreements with Harvard Medical School’s 16 associated hospitals and research institutes. As a member of the Dean’s cabinet, she is responsible for academic oversight of appointments and promotions in the Faculty of Medicine.

Dr. Daye graduated from the University of Pennsylvania MD-PhD program, with election to Alpha Omega Alpha. During residency, she designed and implemented the James H. Thrall management and leadership training (MLT) program for radiology residents at MGH. Dr. Daye completed her PhD in Bioengineering as an HHMI-NIBIB Interfaces scholar in imaging sciences. Her current research centers on the applications of artificial intelligence, machine learning and mHealth in precision medicine and value-based care delivery models. To date, Dr. Daye’s research has resulted in 25 peer-reviewed publications and more than 30 accepted abstracts and presentations at both national and international scientific meetings. For her research, Dr. Daye is the recipient of a number of awards that include the Association of American Physicians Stanley J. Korsmeyer Young Investigator Award, the Association of University Radiologists (AUR) Memorial Award and the 40 under 40 MedTech Boston Healthcare Innovators award. Dr. Daye was also selected as a Howard Hughes Medical Institute Gilliam fellow and a junior fellow of the International Society of Magnetic Resonance in Medicine (ISMRM). Dr. Daye previously served as the President of the American Physician Scientists Association, a national association representing physician-scientist trainees in 96 U.S. medical schools. She currently serves on the board of directors. For her local and national leadership roles, Dr. Daye was the recipient of the AMA Foundation Leadership Award. Dr. Daye is hoping to pursue a career as a physician-scientist in interventional radiology.

Dr. Mary Elizabeth Oates is a Diagnostic Radiology Specialist in Lexington, Kentucky. She graduated with honors from Boston University School Of Medicine in 1981. Having more than 37 years of diverse experiences, especially in Diagnostic Radiology, Nuclear Medicine, Dr. Mary Elizabeth Oates affiliates with many hospitals including University Of Kentucky Hospital, Rockcastle Regional Hospital & Respiratory Care Ct, and cooperates with other doctors and specialists in medical group Kentucky Medical Services Foundation, Inc.

Jacqueline R. Kelly, MD, MSc, received her Bachelor of Arts in Human Evolutionary Biology with minors in Spanish and French language from Harvard College in 2008, her MD from Boston University in 2014, and her Master of Science degree in Radiation Biology from the University of Oxford in 2013, where she conducted basic science research exploring the use of histone deacetylase inhibitors as radiosensitizers in bladder cancer cells.

Her research interests include comparative effectiveness and outcomes research within clinical oncology as well as clinical trial design. She recently completed the ASCO/AARC Methods in Clinical Cancer Research Workshop focusing on trial design and is in the process of launching a phase II head and neck trial at Yale. She is currently receiving further training as a Health Sciences Research Fellow as part of the Yale National Clinical Scholars Program. Upon graduating in July 2019, she plans to pursue a career as an academic radiation oncologist.

Foundation of the American Society of Neuroradiology (Foundation), American College of Radiology (ACR), and American Association for Women Radiologists (AAWR) have established an award to provide leadership opportunities for women in neuroradiology. Since neuroradiologists must be leaders in the field, this award is for mid-career women with demonstrated experience and promise for leadership in neuroradiology and/or radiology overall. The objectives are to provide the awardee with additional skills and insights to enhance opportunities for advancement.